Page 4 - Bioreference Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioreference health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioreference Health Today - Breaking & Trending Today

OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript February 27, 2024 OPKO Health, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. OPKO Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […] ....

United States , Jeffrey Cohen , Virginia Oncology Group , American Urology Association , Bioreference Health , Urology Association , Adam Logal ,

Opko Health (OPK) Q4 2023 Earnings Call Transcript

OPK earnings call for the period ending December 31, 2023. ....

United States , Yi Chen , Jeffrey Cohen , Charlie Bishop , Maury Raycroft Jefferies , Jeff Cohen Ladenburg Thalmann , Phillip Frost , Lyvonne Briggs , Piper Sandler , Edward Tenthoff , Maury Raycroft , Edward Tenthoff Piper Sandler , Elias Zerhouni , Biomedical Advanced Research , Hc Wainright Co , Opko Health , American Urology Association , Company Analyst , Development Authority , Renal Division , Bioreference Health , Motley Fool Stock Advisor , Stock Advisor , Adam Logal , Chief Executive , Modex Therapeutics ,

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from the fourth quarter and subsequent weeks included the following: ModeX advanced its antiviral and immune-oncology product pipeline. ModeX advanced its pipeline of antiviral and immune-oncology programs utilizing its next-generation multispecific ....

United Arab Emirates , United States , United Kingdom , Lyvonne Briggs , Bruce Voss , Health Inc , Exchange Commission , Bioreference Health , Nextplat Corp , Reference Health , Tmall Global Platform , Tmall Global , Convertible Senior Notes , Convertible Promissory Notes , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements , Opko Health , Fourth Quarter , The Fourth Quarter ,

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

MIAMI, Feb. 27, 2024 OPKO Health, Inc. reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from the fourth quarter and. ....

United Kingdom , United Arab Emirates , United States , Bruce Voss , Lyvonne Briggs , Exchange Commission , Health Inc , Bioreference Health , Globenewswire Inc , Nextplat Corp , Arab Emirates , Reference Health , Tmall Global Platform , Tmall Global , Convertible Senior Notes , Convertible Promissory Notes , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements ,